Media Summary: Updated Approach to Dyslipidemia Management (2025) Dyslipidemia remains one of the strongest modifiable risk factors Sign up to receive Peter's email newsletter: Watch the full episode: Become a ... This Harvard Medical School Continuing Education video examines these key questions: How does lowering LDL-C fit into key ...

3 4 Lipid Shifts Stop - Detailed Analysis & Overview

Updated Approach to Dyslipidemia Management (2025) Dyslipidemia remains one of the strongest modifiable risk factors Sign up to receive Peter's email newsletter: Watch the full episode: Become a ... This Harvard Medical School Continuing Education video examines these key questions: How does lowering LDL-C fit into key ... In this episode, I'm breaking down sections 4.2. Emory Cardiology Friday Fellows Conference 04-10-2026 Speaker: Sarah Ashley, MD. In Episode , Dr Thomas Dayspring joins me to round out our

Emory Cardiology Grand Rounds 03-11-2024 Speaker: John T. Wilkins, MD, MSc, FAHA. SUPPORT/JOIN THE CHANNEL: My goal is to reduce ...

Photo Gallery

3–4% Lipid Shifts? Stop Guessing – Use This Trueness Check Before Your Next Survey | S. Park Podcast
APOE4 & Lipids: Why Your Doctor's Targets Aren't Aggressive Enough (Statin Debate Settled?)
Dyslipedemia Management
The Modern Lipid Playbook Part 2: THE TESTING — Why Your Lipid Panel Isn't Enough
How to lower your apoB
Management of Hyperlipidemia: 2018 ACC/AHA Guideline Update
Who Actually Needs a Statin? (New Lipid Guidelines)
From Evidence to Action: Implementing the 2026 Dyslipidemia Guidelines in Clinical Practice
Practical Pearls - TG-Targets ApoC3 & ANGPTL3 - Jun 2025
Preventing and Treating Cardiovascular Disease | Lipid Series Part 3 | Dr Thomas Dayspring | Ep 253
Assessment and Mitigation of Lipid-Associated CVD Risk in Young Adults
Lipid Transport (Pt. 3)
Sponsored
Sponsored
View Detailed Profile
3–4% Lipid Shifts? Stop Guessing – Use This Trueness Check Before Your Next Survey | S. Park Podcast

3–4% Lipid Shifts? Stop Guessing – Use This Trueness Check Before Your Next Survey | S. Park Podcast

Lab managers know the drill:

APOE4 & Lipids: Why Your Doctor's Targets Aren't Aggressive Enough (Statin Debate Settled?)

APOE4 & Lipids: Why Your Doctor's Targets Aren't Aggressive Enough (Statin Debate Settled?)

Your standard

Sponsored
Dyslipedemia Management

Dyslipedemia Management

Updated Approach to Dyslipidemia Management (2025) Dyslipidemia remains one of the strongest modifiable risk factors

The Modern Lipid Playbook Part 2: THE TESTING — Why Your Lipid Panel Isn't Enough

The Modern Lipid Playbook Part 2: THE TESTING — Why Your Lipid Panel Isn't Enough

The Modern

How to lower your apoB

How to lower your apoB

Sign up to receive Peter's email newsletter: https://bit.ly/4c602k2 Watch the full episode: https://youtu.be/em5xwtivnkg Become a ...

Sponsored
Management of Hyperlipidemia: 2018 ACC/AHA Guideline Update

Management of Hyperlipidemia: 2018 ACC/AHA Guideline Update

This Harvard Medical School Continuing Education video examines these key questions: How does lowering LDL-C fit into key ...

Who Actually Needs a Statin? (New Lipid Guidelines)

Who Actually Needs a Statin? (New Lipid Guidelines)

In this episode, I'm breaking down sections 4.2.

From Evidence to Action: Implementing the 2026 Dyslipidemia Guidelines in Clinical Practice

From Evidence to Action: Implementing the 2026 Dyslipidemia Guidelines in Clinical Practice

Emory Cardiology Friday Fellows Conference 04-10-2026 Speaker: Sarah Ashley, MD.

Practical Pearls - TG-Targets ApoC3 & ANGPTL3 - Jun 2025

Practical Pearls - TG-Targets ApoC3 & ANGPTL3 - Jun 2025

Speaker: Nicholas Marston, MD, MPH.

Preventing and Treating Cardiovascular Disease | Lipid Series Part 3 | Dr Thomas Dayspring | Ep 253

Preventing and Treating Cardiovascular Disease | Lipid Series Part 3 | Dr Thomas Dayspring | Ep 253

In Episode #253, Dr Thomas Dayspring joins me to round out our

Assessment and Mitigation of Lipid-Associated CVD Risk in Young Adults

Assessment and Mitigation of Lipid-Associated CVD Risk in Young Adults

Emory Cardiology Grand Rounds 03-11-2024 Speaker: John T. Wilkins, MD, MSc, FAHA.

Lipid Transport (Pt. 3)

Lipid Transport (Pt. 3)

SUPPORT/JOIN THE CHANNEL: https://www.youtube.com/channel/UCZaDAUF7UEcRXIFvGZu3O9Q/join My goal is to reduce ...